aTyr Pharma (LIFE) Tops Q1 EPS by 1c

aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $27.5 thousand.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family
• Bit Digital (BTBT) Misses Q2 EPS by 27c
• SuperCom (SPCB) Tops Q3 EPS by 43c